Pfizer Inc.

NYSE:PFE

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

💉 Vaccines

Location

United States

Market Cap

USD 139.75 B

Share Price

USD 24.58

Avg Daily Volume

42,462,976

Change (1 day)

0.00%

Change (1 year)

-13.91%

Change (YTD)

-7.35%

Pfizer Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 29, 2025: 35.68%

Pfizer Inc. EBITDA Margin is 35.68% for the Trailing 12 Months (TTM) ending June 29, 2025, a 265.65% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Pfizer Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 9.76%, a -74.48% change year over year.
Pfizer Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending July 02, 2023 was 38.24%, a 0.84% change year over year.
Pfizer Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending July 03, 2022 was 37.92%, a 5.22% change year over year.
Pfizer Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending July 04, 2021 was 36.04%, a -25.68% change year over year.